Presenting the All New Automation/Pharmacovigilance Knowledge Hub

Apr 15, 2020

Pharmacovigilance (PV) is the process in drug development that ensures safe, innovative, and high-quality medicinal products get released to the market. The World Health Organization describes how PV achieves this with “the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem.”

Automation, fueled by Artificial Intelligence (AI), machine learning, deep learning, and natural language processing, brings substantial benefits. By automating daily activities and repetitive tasks, companies experience time savings and decreasing costs. Up to 30% efficiency gains can be achieved using automation solutions. Other benefits include increased case processing quality and significant error reduction.

Managing tasks in the drug development process via automation technologies equates to these processes being more efficient, effective, and less time-consuming. Additionally, the cost of case reporting becomes lower while data quality is improved. Significant time savings are also witnessed in pharmacovigilance when utilizing automation. Additionally, PV flourishes when there is an understanding of unstructured data, the capacity to complete follow-up management, and the functionality of a touchless language translation process.

ArisGlobal has created an Automation in Pharmacovigilance Knowledge Hub to help explain, in easily digestible terms, everything you need to know about automation in PV. Learn more about the areas you should automate, the benefits of automation, our approach to automation in PV, plus much more.

The world of automation in pharmacovigilance is now at your fingertips. For more information on automation and pharmacovigilance, visit our knowledge hub: https://www.arisglobal.com/automation-pharmacovigilance/.
LATEST NEWS

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Erika Thomas
ArisGlobal
+305-726-6601 | ethomas@arisglobal.com